NCT06648057 2026-03-18
Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
CHA University
Recruiting
CHA University
CHA University
CHA University
Institute of Oncology Ljubljana
The Institute of Molecular and Translational Medicine, Czech Republic
Dana-Farber Cancer Institute
National University Hospital, Singapore
Boston Children's Hospital